Clinical Trial Update: Evaluation of Ocoxin-Viusid® in Advanced Pancreatic Adenocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Ocoxin-Viusid in advanced pancreatic adenocarcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Digestive System Neoplasms
• Endocrine Gland Neoplasms
• Pancreatic Adenocarcinoma
• Pancreatic Cancer
• Pancreatic Diseases
• Pancreatic Neoplasms

Drugs mentioned

• Ocoxin®-Viusid®

Snippet

Sponsor: Catalysis SL | Conditions: Adenocarcinoma of the Pancreas, Pancreatic Cancer | Phase 2 | Status: COMPLETED